Magazine

Returning to Play: The Evolution of Cardiac Guidelines for Athletes with COVID-19

Our understanding of COVID-19 has evolved greatly since its first appearance in the U.S. in early 2020. Though our knowledge remains incomplete, we’ve learned a lot about the pathophysiology of the virus—especially its unique effects on the heart.

Oasis of Opportunity: Strategies for Managing Healthcare’s Data Deluge

Forward-looking providers are converting reams of data from myriad sources into innovative new ways to deliver healthcare and improve efficiencies.

Stirring the Pot: Cannabis & Cardiology—How & Why to Talk with Patients About Marijuana Use

As use of cannabis products increases and evidence of possible cardiovascular harm mounts, it’s time for cardiologists to start having conversations with their patients.

Pop Goes the Pillbox: Will Polypharmacy Problems Limit the Adoption of SGLT2 Inhibitors?

Following data supporting their use for heart failure and type 2 diabetes, will sodium-glucose cotransporter 2 inhibitors find a spot in the heart failure armamentarium?

Whether Actionable or Adorable, Data Takes Patience (& Patient-centeredness)

Even the best analytics won’t replace human interaction; protect your time with patients and colleagues. Focus on the patient-centered metrics, and try to be patient. It takes time to turn a mess into a masterpiece.

Data Dilemma: Taming Healthcare’s Beautiful Beast

To get the operational perspective, CVB hosted a roundtable discussion with service line leaders about the opportunities and challenges they encounter around data.

Oasis of Opportunity: Strategies for Managing Healthcare’s Data Deluge

Forward-looking providers are converting reams of data from myriad sources into innovative new ways to deliver healthcare and improve efficiencies.

Stirring the Pot: Cannabis & Cardiology—How & Why to Talk with Patients About Marijuana Use

As use of cannabis products increases and evidence of possible cardiovascular harm mounts, it’s time for cardiologists to start having conversations with their patients.

Live in Las Vegas: SCAI.19 Expands Focus on Live Cases

SCAI has diversified its planning committees and expanded the focus on live cases for its 2019 scientific sessions, says Program Chair Sunil Rao, MD.

The Opioid Crisis May Be Coming to Your Cardiology Practice

Where I live in Pennsylvania, not far from the “Heroin Highway,” the local news delivers frequent but superficial glimpses of the impact of the opioid epidemic on families and our communities. Statistics underscore such stories: More than 70,000 drug over-dose deaths just in 2017 with an associated “economic burden” exceeding $78 billion per year.

Stop the Bleeding: Hemorrhagic Complications Gain Ground on Ischemia in Treating Patients with Arrhythmia

Atrial fibrillation patients with coronary artery disease pose a delicate balancing act for physicians. A growing awareness of bleeding vs. ischemic risks could soon lead to a steadier therapeutic response.

Challenges of Infective Endocarditis: The Opioid Crisis Hits Home & Cardiologists Can’t Go It Alone

As rates of infective endocarditis among intravenous drug users skyrocket, cardiologists are finding that treating the heart condition without addressing the disease of addiction contributes to readmissions and mortality.